Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Hypoxic ADSC-CM-Loaded Separable Bilayer Micropatterned Dressing Improved Diabetic Wound Healing via Tissue Integration and Immune Modulation.

Huang J., Liang K., Wang Z., Lin Z., Liu J., Li N.

Animal Study on Diabetic Foot, Chronic Wound, Immune Modulation, published in ACS Appl Mater Interfaces (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
ACS Appl Mater Interfaces (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40539763
DOI
10.1021/acsami.5c05220

Abstract (original English)

Dressings loaded with bioactive factors secreted by adipose-derived stem cells (ADSCs) show potential for diabetic wound healing. However, single functionality and limited integration with wounds hinder their efficacy. Hence, a bilayer micropattern dressing (BMPD) consisting of micropatterned scaffold G5A0.4-MP and an antiadhesion PDMS/A1 layer is prepared. G5A0.4-MP facilitates tissue integration, while the PDMS/A1 layer protects wounds and prevents adhesion. G5A0.4-MP is cross-linked through a photomask, resulting in cylindrical hydrogels with a diameter of 387.4 ± 27.2 μm and a thickness of 417.8 ± 32.3 μm. The swelling ratios of these two layers are significantly different, which allows the detachment of G5A0.4-MP from the PDMS/A1 layer to integrate well with the granulation tissue after lyophilized BMPDs are applied onto wounds. BMPDs with different micropattern interspaces are obtained by changing photomasks, among which the one with an interspace of 100 μm (BMPD-100) shows the best effect on improving wound healing. Hence, a hypoxic ADSC-conditioned medium is loaded into G5A0.4-MP to obtain CM@BMPD-100. CM@BMPD-100 enriches MMP-9 into the micropatterned hydrogel and downregulates the corresponding content in granulation tissue. Additionally, it promotes cell proliferation, regulates the polarization of macrophages from M1 type to M2 type, and enhances vascularization and

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Wound HealingAnimalsHydrogelsBandagesStem CellsAdipose TissueCulture Media, ConditionedMiceHumansDiabetes Mellitus, Experimental

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research